Literature DB >> 25465599

Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus.

Beatriz R Bouvet1, Cecilia V Paparella1, Sandra M M Arriaga1, Adriana L Monje2, Ana M Amarilla1, Adriana M Almará1.   

Abstract

OBJECTIVE: To evaluate the clinical usefulness of urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion for the detection of early tubular damage in type 2 diabetes mellitus (T2DM). SUBJECTS AND METHODS: Thirty six patients with T2DM were divided into two groups based on urinary albumin to creatinine ratio (ACR): normoalbuminuria (ACR <30 mg/g; n=19) and microalbuminuria (ACR =30-300 mg/g; n=17). The following parameters were determined in both groups: urinary NAG and albumin, serum and urine creatinine, fasting plasma glucose and glycated hemoglobin (HbA1c).
RESULTS: Urinary NAG levels [Units/g creatinine; median (range)] were significantly increased in microalbuminuria group [17.0 (5.9 - 23.3)] compared to normoalbuminuria group [4.4 (1.5 - 9.2)] (P<0.001). No differences between groups were observed in fasting glucose, HbA1c, serum creatinine levels and estimated glomerular filtration rates (eGFR). Urinary NAG positively correlated with ACR (r=0.628; p<0.0001), while no significant association was observed between NAG and glycemia, HbA1c, serum creatinine and eGFR.
CONCLUSIONS: The increase of urinary NAG at the microalbuminuria stage of diabetic nephropathy (DN) suggests that tubular dysfunction is already present in this period. The significant positive association between urinary NAG excretion and ACR indicates the possible clinical application of urinary NAG as a complementary marker for early detection of DN in T2DM.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25465599     DOI: 10.1590/0004-2730000003010

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  7 in total

Review 1.  Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy.

Authors:  Zubair Ilyas; Joumana T Chaiban; Armand Krikorian
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

2.  Urinary N-acetyl-beta-d-glucosaminidase (NAG) with neutrophil gelatinase-associated lipocalin (NGAL) improves the diagnostic value for proximal tubule damage in diabetic kidney disease.

Authors:  Khalid Siddiqui; Basim Al-Malki; Teena Puthiyaparampil George; Shaik Sarfaraz Nawaz; Khalid Al Rubeaan
Journal:  3 Biotech       Date:  2019-02-04       Impact factor: 2.406

3.  Urinary biomarkers for early diabetic nephropathy in type 2 diabetic patients.

Authors:  Temesgen Fiseha
Journal:  Biomark Res       Date:  2015-07-04

Review 4.  Biomarkers of diabetic kidney disease.

Authors:  Helen M Colhoun; M Loredana Marcovecchio
Journal:  Diabetologia       Date:  2018-03-08       Impact factor: 10.122

5.  The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes.

Authors:  Deyuan Zhang; Shandong Ye; Tianrong Pan
Journal:  PeerJ       Date:  2019-06-11       Impact factor: 2.984

Review 6.  Review of potential biomarkers of inflammation and kidney injury in diabetic kidney disease.

Authors:  Vuthi Khanijou; Neda Zafari; Melinda T Coughlan; Richard J MacIsaac; Elif I Ekinci
Journal:  Diabetes Metab Res Rev       Date:  2022-07-11       Impact factor: 8.128

Review 7.  Urinary Markers of Tubular Injury in Early Diabetic Nephropathy.

Authors:  Temesgen Fiseha; Zemenu Tamir
Journal:  Int J Nephrol       Date:  2016-05-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.